- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.35 Å
- Oligo State
- monomer
- Ligands
- 18 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 1 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 1 x XWV: 5-{4-[(3R)-3-methylmorpholin-4-yl]-6-[1-(S-methylsulfonimidoyl)cyclopropyl]pyrimidin-2-yl}isoquinoline(Non-covalent)
XWV.20: 14 residues within 4Å:- Chain A: W.156, P.157, F.158, H.160, P.161, V.162, N.163, F.166, V.167, Y.170, Y.212, N.213, Y.219
- Ligands: EDO.15
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:W.156, A:V.162, A:F.166, A:Y.212
- Hydrogen bonds: A:N.163, A:N.213
- Water bridges: A:P.161, A:V.162, A:Y.170, A:Y.219
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Karim, M.R. et al., Crystal structure of the tandem bromodomain (BD1, BD2) of human TAF1 bound to ZS1-585. To Be Published
- Release Date
- 2021-07-14
- Peptides
- Transcription initiation factor TFIID subunit 1: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.35 Å
- Oligo State
- monomer
- Ligands
- 18 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 1 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 1 x XWV: 5-{4-[(3R)-3-methylmorpholin-4-yl]-6-[1-(S-methylsulfonimidoyl)cyclopropyl]pyrimidin-2-yl}isoquinoline(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Karim, M.R. et al., Crystal structure of the tandem bromodomain (BD1, BD2) of human TAF1 bound to ZS1-585. To Be Published
- Release Date
- 2021-07-14
- Peptides
- Transcription initiation factor TFIID subunit 1: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A